OpenEvidence
OpenEvidence is a leading medical information platform that aggregates, synthesizes, and visualizes clinically relevant evidence to assist healthcare professionals in making evidence-based decisions. Launched from the Mayo Clinic Platform Accelerate program, it features multimedia and clinical findings from prestigious journals like The New England Journal of Medicine and JAMA. The platform is free for verified U.S. healthcare professionals and is trusted by over 10,000 care centers across the United States. OpenEvidence aims to tackle the challenge of information overload in medicine by providing accessible formats for the latest research literature and clinical evidence, thereby improving patient outcomes.
OpenEvidence
OpenEvidence is a leading medical information platform that aggregates, synthesizes, and visualizes clinically relevant evidence to assist healthcare professionals in making evidence-based decisions. Launched from the Mayo Clinic Platform Accelerate program, it features multimedia and clinical findings from prestigious journals like The New England Journal of Medicine and JAMA. The platform is free for verified U.S. healthcare professionals and is trusted by over 10,000 care centers across the United States. OpenEvidence aims to tackle the challenge of information overload in medicine by providing accessible formats for the latest research literature and clinical evidence, thereby improving patient outcomes.
TL;DR
Sector: AI-powered medical information & clinical decision support
Founders: Daniel Nadler; Zachary Ziegler
Users: Free for verified U.S. healthcare professionals; used by 10,000+ care centers (company claim)
Recent financing: $210M Series B announced July 15, 2025
Origin: Launched from the Mayo Clinic Platform Accelerate program
Company Overview
Problem Domain
Medical information overload; need for evidence-based clinical decision support at point of care.
Industry
Healthcare / Healthtech
Funding Track Record
Seed round completed July 2022 (reported)
210000000.00
$210M Series B announced July 15, 2025 (company announcement)
Investor Signal
“Backed by prominent venture investors including Sequoia, Google Ventures (GV), Kleiner Perkins, Coatue, Thrive, Conviction, ICONIQ, Greycroft, Breyer Capital, and Mayo Clinic (company disclosures)”